Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Toth

Showing results (181-190 of 425) with videos related to

Pageof 43
Sort By:
Trends in Cardiovascular Medicine|April 19, 2021
Coronary heart disease risk: Low-density lipoprotein and beyondGabriel E Shaya, Thorsten M Leucker, Steven R Jones, et al.
Trends in Pharmacological Sciences|July 5, 2018
Novel Therapeutic Targets for Managing DyslipidemiaVasanth Sathiyakumar, Karan Kapoor, Steven R Jones, et al.
Journal of Clinical Lipidology|May 6, 2014
A clinician's guide to statin drug-drug interactionsKenneth A Kellick, Michael Bottorff, Peter P Toth, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 10, 2019
Spotlight from the American Society for Preventive Cardiology on Key Features of the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood CholesterolNathan D Wong, Ezra A Amsterdam, Christie Ballantyne, et al.
Drugs|April 17, 2019
Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical TrialsFederica Fogacci, Nicola Ferri, Peter P Toth, et al.
Clinical Cardiology|March 23, 2017
PCSK9 inhibitor access barriers-issues and recommendations: Improving the access process for patients, clinicians and payersSeth J Baum, Peter P Toth, James A Underberg, et al.
Journal of Clinical Lipidology|September 26, 2017
Genetic effects on efficacy of lipid-lowering drugsWilliam Virgil Brown, Alan S Brown, Brian A Ference, et al.
Reviews in Cardiovascular Medicine|April 26, 2014
Use of microsomal triglyceride transfer protein inhibitors in patients with homozygous familial hypercholesterolemia: translating clinical trial experience into clinical practicePeter P Toth, Prediman K Shah, Michael J Wilkinson, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 6, 2020
Management of pregnancy-related hypertensive disorders in patients infected with SARS CoV-2: pharmacological and clinical issuesSilvia Fogacci, Federica Fogacci, Elda Favari, et al.
Drugs|March 18, 2022
Contemporary Management of DyslipidemiaRichard A Ferraro, Thorsten Leucker, Seth S Martin, et al.
Pageof 43

Showing results (181-190 of 425) with videos related to

Sort By:
Pageof 43
Trends in Cardiovascular Medicine|April 19, 2021
Coronary heart disease risk: Low-density lipoprotein and beyondGabriel E Shaya, Thorsten M Leucker, Steven R Jones, et al.
Trends in Pharmacological Sciences|July 5, 2018
Novel Therapeutic Targets for Managing DyslipidemiaVasanth Sathiyakumar, Karan Kapoor, Steven R Jones, et al.
Journal of Clinical Lipidology|May 6, 2014
A clinician's guide to statin drug-drug interactionsKenneth A Kellick, Michael Bottorff, Peter P Toth, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 10, 2019
Spotlight from the American Society for Preventive Cardiology on Key Features of the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood CholesterolNathan D Wong, Ezra A Amsterdam, Christie Ballantyne, et al.
Drugs|April 17, 2019
Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical TrialsFederica Fogacci, Nicola Ferri, Peter P Toth, et al.
Clinical Cardiology|March 23, 2017
PCSK9 inhibitor access barriers-issues and recommendations: Improving the access process for patients, clinicians and payersSeth J Baum, Peter P Toth, James A Underberg, et al.
Journal of Clinical Lipidology|September 26, 2017
Genetic effects on efficacy of lipid-lowering drugsWilliam Virgil Brown, Alan S Brown, Brian A Ference, et al.
Reviews in Cardiovascular Medicine|April 26, 2014
Use of microsomal triglyceride transfer protein inhibitors in patients with homozygous familial hypercholesterolemia: translating clinical trial experience into clinical practicePeter P Toth, Prediman K Shah, Michael J Wilkinson, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 6, 2020
Management of pregnancy-related hypertensive disorders in patients infected with SARS CoV-2: pharmacological and clinical issuesSilvia Fogacci, Federica Fogacci, Elda Favari, et al.
Drugs|March 18, 2022
Contemporary Management of DyslipidemiaRichard A Ferraro, Thorsten Leucker, Seth S Martin, et al.
Pageof 43